New imaging agents could sharpen detection of rare childhood and adult cancers
NCT ID NCT07195500
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study tests whether special PET scans using targeted tracers can more accurately find and stage neuroblastoma and pheochromocytoma/paraganglioma tumors than current methods. About 30 people aged 1 to 70 will receive an injection of a radioactive tracer and then have a PET scan. Their scan results will be compared with tissue samples to see how well the imaging detects cancer. The goal is to improve diagnosis and staging without invasive procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanjing First Hospital
RECRUITINGNanjing, Jiangsu, 210000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.